Share

QUB opens high tech Precision Medicine Centre of Excellence

  • The new state-of-the-art laboratory will bring together high-throughput genomics, artificial intelligence and big data analytics.

    Queen’s University Belfast officially opened the Precision Medicine Centre of Excellence (PMC) on Wednesday ( April 10), which the university hopes will radically change the landscape of modern medicine in Northern Ireland and beyond.

    The PMC is a new laboratory based at Queen’s University Belfast campus, boasting state-of-the-art technology, which will bring together high-throughput genomics, artificial intelligence and big data analytics in a fully integrated fashion.

    “No longer a ‘one size fits all’, we have seen a major shift towards precision medicine in recent years, focusing on tailored treatment for patients," said Professor Manuel Salto-Tellez.

    “The Precision Medicine Centre of Excellence will provide the necessary infrastructure to meet the increasing demands in the changing field of healthcare and industry in terms of technologies and expertise.

    "The PMC has the potential to boost regional and national biotech companies in the space of artificial intelligence and genomics, while improving the lives of oncology patients across Northern Ireland and beyond."

    RELATED: QUB researcher discovers new way to fight sight-threatening diseases

    Precision Medicine Centre (PMC) is co-funded by Invest Northern Ireland, Queen’s University Belfast and the Health and Social Care Research and Development Division of the Public Health Agency.

    It has already attracted over £4m in funding to the local economy and employs nearly 30 data analysts and scientists. 

    Invest NI offered £5.8m of support in 2017 towards the creation of the new centre.

    Professor Manuel Salto-Tellez added: "Our long-term vision for precision cancer medicine is that the NI biomarker industry is a key player in making sure that all cancer patients have access to high-quality, comprehensive and timely molecular characterization of their tumour to inform therapeutic and clinical management.”

    Source: Written based on press release

    About the author

    An article that is attributed to Sync NI Team has either involved multiple authors, written by a contributor or the main body of content is from a press release.

    Got a news-related tip you’d like to see covered on Sync NI? Email the editorial team for our consideration.

Share this story